strategy, page-4

Who knows what's going on in commercial confidence? These things take time, one day we may very well wake up to a very big RNAi deal with Chinese pharma, or a big Chinese government grant to Biomics to accelerate the Hep B program. The US government gave a $230 million or so grant to Biota to commercialise their LANI compound, why wouldn't the Chinese government do something similar for Hepatitis B? In fact, I positively expect that at some stage, companies will be invited to competitively tender for Chinese Hepatitis B research grants to take a compound all the way to market, and in double quick time. As I have mentioned, Hep B is a really big drag on the Chinese economy and as the Chinese have mentioned, it is a top priority. In such a tender situation Biomics/Benitec will put in a tender and it will be hard to see them being refused. All speculative, but it all makes sense and is very congruent with the Chinese plans for biotech.